Twist Bioscience Corporation (TWST) vs U.S. Physical Therapy, Inc. (USPH)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| TWST | USPH | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Medical Care Facilities |
| Size band | MID | SMALL |
| Listing | Nasdaq GS | NYSE |
| Country | United States | United States |
| Theme | life-science-tools | hospitals-and-providers |
| Price and returns | ||
| Last close | $145.25 | $88.65 |
| Return · 1 week | +3.92% | +5.65% |
| Return · 1 month | −19.13% | +2.97% |
| Return · 3 months | +64.03% | +12.22% |
| Return · year to date | +348.44% | +13.89% |
| Return · 1 year | +324.96% | −0.66% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −33.89% | −5.19% |
| 52-week high | $219.71 | $93.50 |
| 52-week low | $23.30 | $58.19 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $9.63B | $1.32B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $302.09M | $15.11M |
| Employees | 979 | 4,653 |
| Valuation | ||
| Price to earnings · trailing | n/a (negative earnings) | 491.83× |
| Price to earnings · forward | n/a (negative forward earnings) | 26.43× |
| Price to sales | 20.38× | 1.64× |
| Price to book | 18.67× | 2.94× |
| Enterprise value to EBITDA | n/a (negative EBITDA) | 19.59× |
| Enterprise value to revenue | 19.14× | 2.49× |
| PEG ratio | — | 2.90 |
| Earnings per share · trailing | -2.23 | 0.18 |
| Profitability | ||
| Gross margin | 51.97% | 18.68% |
| Operating margin | −30.65% | 11.13% |
| Profit margin | −31.66% | 0.33% |
| Return on equity | −29.59% | 6.51% |
| Return on assets | −13.09% | 4.10% |
| Growth | ||
| Revenue growth | +23.20% | +8.50% |
| Earnings growth | — | −56.50% |
| Balance sheet and payout | ||
| Debt / equity (%) | 24.36 | 50.32 |
| Current ratio | 2.67 | 1.27 |
| Dividend yield | 0.00% | 2.08% |
| Payout ratio | — | 1011.11% |
| Trend and volatility | ||
| RSI · 14 | 38.20 | 60.79 |
| ADX · 14 | 25.91 | 17.78 |
| 50-day average | $147.91 | $81.52 |
| 200-day average | $83.26 | $76.52 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 11.43% | 2.58% |
The full TWST analysis
Everything this table leaves out for Twist Bioscience Corporation: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the TWST argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full TWST analysisThe full USPH analysis
Everything this table leaves out for U.S. Physical Therapy, Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the USPH argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full USPH analysis